Paul King

CFO

Paul started 30 years ago as a Series 3 trader. He followed that by starting and taking his biomed portfolio to over $1.2 billion valuation

About

Paul King

Paul started his career almost 30 years ago as a Series 3 trader. He followed that by starting and taking his biomed portfolio from a $6 million valuation to over $1.2 billion. Paul has managed large asset classes in several countries and is an expert at defining and managing risk while delivering consistent growth.

Past experience

Articles by

Paul King

No items found.